Please find enclosed the newspaper clipping regarding the unaudited financial results of the quarter and half year ending 30.09.2025 published in Financial Express, English Newspaper and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hindustan Agrigenetics has submitted to BSE the newspaper clippings of its unaudited standalone financial results for Q2 FY26 (ended 30 Sept 2025) and the half-year, which were published in Financial Express (English) and Jansatta (Hindi) on 16 November 2025. The company reported zero revenue from operations in Q2 FY26, with total income of ₹25.41 lakhs (mostly interest and other income of ₹24.62 lakhs) and a profit after tax of ₹18.85 lakhs, giving an EPS of ₹0.43. For the half-year (H1 FY26), total income stood at ₹80.89 lakhs and profit after tax was ₹59.05 lakhs with EPS of ₹1.34, compared to a loss of ₹30.50 lakhs for the full previous fiscal year (FY25). Paid-up share capital remained at ₹440.02 lakhs and total reserves at ₹821.37 lakhs as on 30 September 2025.
The company swung to a profit in H1 FY26 after reporting a full-year loss in FY25, but its core operating revenue remains negligible, with earnings driven largely by interest income and investment value changes. For shareholders, this signals improving short-term profitability but limited core business activity, which may keep the stock thinly traded and results-driven.